FBXO31抑制了CD147 (+) 黑色素瘤干细胞的干细胞特性
Jian Guan1,2, Shenglin Wu3, Renyi Liang4
1Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.
Open life sciences
|August 18, 2025
概括
FBXO31抑制黑色素瘤干细胞的迁移,入侵和干性. 这一发现对于理解和潜在地通过向黑色素瘤干细胞来预防恶性癌症的发展至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症干细胞研究研究
背景情况:
- 黑色素瘤干细胞驱动癌症的进展.
- 确定调节黑色素瘤干细胞特性的因素对于治疗策略至关重要.
研究的目的:
- 调查FBXO31在调节黑色素瘤干细胞的干细胞,入侵和迁移中的作用.
- 阐明黑色素瘤干细胞中FBXO31和CD147表达之间的关系.
主要方法:
- 从A375细胞中分离黑色素瘤干细胞 (SP细胞).
- 通过转化检测FBXO31表达和操纵.
- 流细胞计测试以评估CD147的表达.
- 在体外测定球状体的形成,迁移和入侵.
- 在体内对裸体小鼠进行体内研究,以评估瘤生长和转移.
主要成果:
- 发现FBXO31表达在黑色素瘤干细胞中受到下调.
- FBXO31转染减少了CD147阳性细胞的比例.
- CD147阳性细胞表现出增强的干性,迁移和入侵,这些被FBXO31.1.抑制.
- 在体内实验证实FBXO31可以抑制CD147阳性细胞驱动的瘤生长和转移.
结论:
- FBXO31在CD147阳性黑色素瘤干细胞的迁移,入侵和干细胞中起着抑制作用.
- 向FBXO31可能是通过减少癌症干细胞活性来治疗黑色素瘤的潜在治疗方法.
更多相关视频
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.4K
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
10.0K
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
